Tryp Therapeutics and Exopharm Limited Announce Completion of Plan of Arrangement

KELOWNA, BC / ACCESSWIRE / May 1, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF) and Exopharm Limited ACN 163 765 991 ("Exopharm") are pleased to announce that completion of the previously announced plan of arrangement (the "Arrangement") effe...

Related Keywords

Michigan ,United States ,Australia ,Massachusetts ,United Kingdom ,Kelowna ,British Columbia ,Canada ,Australian ,Canadian ,British ,Peter Molloy ,Australian Securities Exchange ,Canadian Securities Exchange ,Tryp Therapeutics Inc ,Supreme Court ,Exopharm Limited ,Computershare Investor Services Inc ,University Of Michigan ,Tryptamine Therapeutics ,University Of Florida ,Tryp Therapeutics ,Business Corporations Act ,Tryp Share ,Computershare Investor Services ,Tryp Shares ,Exopharm Shares ,Massachusetts General Hospital ,